Author: Medtronic, Inc.

Posted Date:

April 13, 2026

Medtronic to announce financial results for its fourth quarter and full fiscal year 2026

Medtronic, Inc.

April 13, 2026
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures

Medtronic, Inc.

March 27, 2026
Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain

Medtronic, Inc.

March 24, 2026
Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Medtronic, Inc.

March 23, 2026
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care

Medtronic, Inc.

March 10, 2026
MiniMed to begin trading on Nasdaq Global Select Market

Medtronic, Inc.

March 6, 2026
Medtronic announces cash dividend for fourth quarter of fiscal year 2026

Medtronic, Inc.

March 5, 2026
Medtronic CFO Thierry Piéton to speak at upcoming investor conferences

Medtronic, Inc.

March 3, 2026
Medtronic begins EMEA commercial launch of MiniMed Go Smart MDI system with Simplera sensor

Medtronic, Inc.

February 25, 2026
MiniMed announces launch of IPO roadshow

Medtronic, Inc.

February 24, 2026